Patents by Inventor Cécile BOYER

Cécile BOYER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes
    Patent number: 10632154
    Abstract: The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si-HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: April 28, 2020
    Assignees: Ecole Nationale Veterinaire, Chu Nantes, Universite de Nantes, Institute National de la Sante et de la Recherche Medicale
    Inventors: Jean-Marie Bach, Mathilde Mosser, Apolline Salama, Anne Moure, Xavier Leveque, Pierre Weiss, Jérôme Guicheux, Cécile Boyer, David Riochet
  • SI-HPMC-ENCAPSULATED INSULIN-PRODUCING CELLS FOR THE TREATMENT OF TYPE 1 DIABETES
    Publication number: 20180318358
    Abstract: The present invention relates to the use of insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si—HPMC) for the treatment of type 1 diabetes. Methods and kits are also provided for restoring and/or maintaining euglycemia in type 1 diabetic patients and in type 1 prediabetic patients.
    Type: Application
    Filed: November 10, 2016
    Publication date: November 8, 2018
    Inventors: Jean-Marie BACH, Mathilde MOSSER, Apolline SALAMA, Anne MOURE, Xavier LEVEQUE, Pierre WEISS, Jérôme GUICHEUX, Cécile BOYER, David RIOCHET
  • Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
    Patent number: 9603860
    Abstract: A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition, when subjected to an in vitro dissolution test according to the USP XXIII Paddle Method, results in no more than 50% of said active drug initially present being dissolved within 30 minutes, and at least 50% of the active drug being dissolved in a time range from about 3 hours to about 4 hours. The pharmaceutical composition is administered daily to a patient having a BMI of about 25 kg/m2 or more for at least a portion of a treatment cycle. The pharmaceutical composition does not cause a number of days of bleeding events in the patient exceeding an average of 15% per treatment cycle in consecutive treatment cycles of administration after an initial treatment cycle of administration.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: March 28, 2017
    Assignee: LABORATORIOS LEON FARMA SA
    Inventors: Philippe Perrin, Dominique Drouin, Cécile Boyer-Joubert
  • PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME
    Publication number: 20150290222
    Abstract: A pharmaceutical composition comprising an active contraceptive drug and one or more pharmaceutically-acceptable excipients. The pharmaceutical composition, when subjected to an in vitro dissolution test according to the USP XXIII Paddle Method, results in no more than 50% of said active drug initially present being dissolved within 30 minutes, and at least 50% of the active drug being dissolved in a time range from about 3 hours to about 4 hours. The pharmaceutical composition is administered daily to a patient having a BMI of about 25 kg/m2 or more for at least a portion of a treatment cycle. The pharmaceutical composition does not cause a number of days of bleeding events in the patient exceeding an average of 15% per treatment cycle in consecutive treatment cycles of administration after an initial treatment cycle of administration.
    Type: Application
    Filed: June 23, 2015
    Publication date: October 15, 2015
    Inventors: Philippe PERRIN, Dominque DROUIN, Cécile BOYER-JOUBERT